Description:Pruritus in PBC arises from synergistic cholestasis and gut microbiome-metabolite dysregulation. Cholestyramine mitigates symptoms by modulating the microbiome - metabolite - host axis, highlighting its therapeutic potential through microbiota remodeling and metabolic homeostasis restoration.